Article

Vectura Partners with Cannabinoid Medicines Company

Vectura will provide preclinical development services for Incannex’s inhaled drug product for the treatment of traumatic brain injury.

Vectura, a contract development and manufacturing organization announced an agreement with Incannex Healthcare Limited, an Australian cannabinoid medicines development company, to provide preclinical development services for IHL-216A, an inhaled drug product for the treatment of traumatic brain injury (TBI).

IHL-216A a combination of cannabidiol with the anesthetic isoflurane, has been found in studies by Incannex to reduce neuronal damage, neuroinflammation, and behavioral deficits resulting from TBI. The combination drug is designed to be administered soon after head trauma, thereby reducing secondary brain injuries.

Vectura will conduct studies for formulation screening manufacturing process optimization, stability assessments, and manufacturing a laboratory-scale batch of IHL-216A for toxicological studies.

Incannex is partnering with the Monash Trauma Group at Monash University’s Department of Neuroscience in Australia to conduct an in-vivo study on the protective effect of IHL-216A in sports concussion, based on a model of TBI developed with the National Football League (NFL). Vectura reports it will further develop the IHL-216A formulation in parallel with the in-vivo experiments in advance of clinical trials.

Source: Vectura

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
Simona Guidi, Associate Director, ProPharma
Tore Bergsteiner
Related Content